We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

130 hedge funds and large institutions have $811M invested in Sarepta Therapeutics in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more capital invested

Capital invested by funds: $321M → $811M (+$490M)

121% more call options, than puts

Call options by funds: $89.5M | Put options by funds: $40.5M

114% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 14

14% more funds holding

Funds holding: 114 → 130 (+16)

13% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 39

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
130
Holders Change
+16
Holders Change %
+14.04%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
44
Reduced
39
Closed
14
Calls
$89.5M
Puts
$40.5M
Net Calls
+$49M
Net Calls Change
+$21.2M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.7M
2
PA
Perceptive Advisors
New York
+$12.4M
3
Invesco
Invesco
Georgia
+$10.1M
4
Jennison Associates
Jennison Associates
New York
+$7.22M
5
EA
Emerald Advisers
Pennsylvania
+$7.16M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.7M
2
State Street
State Street
Massachusetts
-$12.4M
3
PC
PointState Capital
New York
-$3.58M
4
GIM
Granahan Investment Management
Massachusetts
-$3.27M
5
TCM
Tekla Capital Management
Massachusetts
-$3.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$6.01M -$1.38M -67,611 -25%
Deutsche Bank
27
Deutsche Bank
Germany
$5.9M -$633K -30,966 -14%
Lord, Abbett & Co
28
Lord, Abbett & Co
New Jersey
$5.82M +$3.91M +191,314 New
BIM
29
BlackRock Investment Management
Delaware
$5.45M +$570K +27,867 +18%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$5.39M – – –
KCM
31
Kornitzer Capital Management
Kansas
$4.87M -$9.3K -455 -0.3%
SFM
32
Sphera Funds Management
Israel
$4.57M +$3.07M +150,000 New
CS
33
Credit Suisse
Switzerland
$4.29M +$714K +34,916 +33%
Charles Schwab
34
Charles Schwab
California
$3.83M +$318K +15,536 +14%
UBS Group
35
UBS Group
Switzerland
$3.8M +$872K +42,665 +52%
Morgan Stanley
36
Morgan Stanley
New York
$3.68M +$984K +48,123 +66%
Citadel Advisors
37
Citadel Advisors
Florida
$3.43M +$1.95M +95,311 +544%
TA
38
Teachers Advisors
New York
$3.32M -$75.1K -3,671 -3%
Goldman Sachs
39
Goldman Sachs
New York
$3.25M +$972K +47,547 +80%
Ameriprise
40
Ameriprise
Minnesota
$3.25M +$1.7M +83,262 +356%
OAM
41
Oxford Asset Management
United Kingdom
$3.13M +$2.1M +102,692 New
Macquarie Group
42
Macquarie Group
Australia
$2.74M +$859K +42,000 +88%
BCA
43
Benchmark Capital Advisors
New York
$2.69M -$65.4K -3,200 -3%
PP
44
PDT Partners
New York
$2.31M +$1.55M +75,819 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$2.31M +$30.7K +1,503 +2%
SM
46
Sabby Management
Florida
$2.18M +$1.02M +49,657 +226%
AllianceBernstein
47
AllianceBernstein
Tennessee
$2.1M +$178K +8,700 +14%
FAM
48
Fred Alger Management
New York
$1.97M +$1.32M +64,600 New
MOACM
49
Mutual of America Capital Management
New York
$1.82M – – –
Jane Street
50
Jane Street
New York
$1.66M +$770K +37,651 +221%
1
2
3 4 5

SRPT Hedge Fund Activity: Q2 2015 in Review

130 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q2 2015, worth a combined $811M — up 153% from $321M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SRPT positions and 14 closed out — a net gain of 16 holders — while 44 added to existing stakes and 39 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $16.7M. The largest seller was Point72 Asset Management, cutting an estimated $15.7M.

  • 130 institutional investors held Sarepta Therapeutics (SRPT) as of Q2 2015, up from 114 in Q1 2015.
  • Funds reported $811M of Sarepta Therapeutics stock for Q2 2015, up 153% quarter-over-quarter.
  • 30 funds opened new Sarepta Therapeutics positions in Q2 2015 and 14 closed out, a net change of +16 holders.
  • The largest Sarepta Therapeutics buyer in Q2 2015 was Fidelity Investments, an estimated $16.7M added.
  • The largest Sarepta Therapeutics seller in Q2 2015 was Point72 Asset Management, an estimated $15.7M sold.

Based on aggregated 13F filings for Q2 2015.